Literature DB >> 16144836

Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation.

Jasna A Marjanovic1, Zhenyu Li, Aleksandra Stojanovic, Xiaoping Du.   

Abstract

Nitric oxide (NO) stimulates soluble guanylyl cyclase and, thus, enhances cyclic guanosine monophosphate (cGMP) levels. It is a currently prevailing concept that NO inhibits platelet activation. This concept, however, does not fully explain why platelet agonists stimulate NO production. Here we show that a major platelet NO synthase (NOS) isoform, NOS3, plays a stimulatory role in platelet secretion and aggregation induced by low doses of platelet agonists. Furthermore, we show that NOS3 promotes thrombosis in vivo. The stimulatory role of NOS is mediated by soluble guanylyl cyclase and results from a cGMP-dependent stimulation of platelet granule secretion. These findings delineate a novel signaling pathway in which agonists sequentially activate NOS3, elevate cGMP, and induce platelet secretion and aggregation. Our data also suggest that NO plays a biphasic role in platelet activation, a stimulatory role at low NO concentrations and an inhibitory role at high NO concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16144836     DOI: 10.1074/jbc.M506518200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway.

Authors:  Guoying Zhang; Jingyan Han; Emily J Welch; Richard D Ye; Tatyana A Voyno-Yasenetskaya; Asrar B Malik; Xiaoping Du; Zhenyu Li
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

2.  Akt signaling in platelets and thrombosis.

Authors:  Donna S Woulfe
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

3.  An important role of the SRC family kinase Lyn in stimulating platelet granule secretion.

Authors:  Zhenyu Li; Guoying Zhang; Junling Liu; Aleksandra Stojanovic; Changgeng Ruan; Clifford A Lowell; Xiaoping Du
Journal:  J Biol Chem       Date:  2010-02-26       Impact factor: 5.157

4.  The role of Rac1 in glycoprotein Ib-IX-mediated signal transduction and integrin activation.

Authors:  M Keegan Delaney; Junling Liu; Yi Zheng; Michael C Berndt; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-09-20       Impact factor: 8.311

5.  Biphasic roles for soluble guanylyl cyclase (sGC) in platelet activation.

Authors:  Guoying Zhang; Binggang Xiang; Anping Dong; Radek C Skoda; Alan Daugherty; Susan S Smyth; Xiaoping Du; Zhenyu Li
Journal:  Blood       Date:  2011-07-29       Impact factor: 22.113

6.  High-loading Gα13-binding EXE peptide nanoparticles prevent thrombosis and protect mice from cardiac ischemia/reperfusion injury.

Authors:  Aiming Pang; Ni Cheng; Yujie Cui; Yanyan Bai; Zhigang Hong; M Keegan Delaney; Yaping Zhang; Claire Chang; Can Wang; Chang Liu; Paola Leon Plata; Alexander Zakharov; Kasim Kabirov; Jalees Rehman; Randal A Skidgel; Asrar B Malik; Ying Liu; Aleksander Lyubimov; Minyi Gu; Xiaoping Du
Journal:  Sci Transl Med       Date:  2020-07-15       Impact factor: 17.956

7.  Thromboxane and the thromboxane receptor in cardiovascular disease.

Authors:  Emer M Smyth
Journal:  Clin Lipidol       Date:  2010-04-01

Review 8.  Refinement, reduction and replacement approaches to in vivo cardiovascular research.

Authors:  Michael Emerson
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

9.  LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis.

Authors:  Brian Estevez; Aleksandra Stojanovic-Terpo; M Keegan Delaney; Kelly A O'Brien; Michael C Berndt; Changgeng Ruan; Xiaoping Du
Journal:  Blood       Date:  2013-04-25       Impact factor: 22.113

10.  GSK3beta is a negative regulator of platelet function and thrombosis.

Authors:  Dongjun Li; Shelley August; Donna S Woulfe
Journal:  Blood       Date:  2008-01-24       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.